{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:39:42Z","timestamp":1792784382163,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sichuan Science and Technology","award":["No. 2020YJ0461"],"award-info":[{"award-number":["No. 2020YJ0461"]}]},{"name":"Foundation of Sichuan Provincial People\u2019s Hospital","award":["No. 2022QN14"],"award-info":[{"award-number":["No. 2022QN14"]}],"id":[{"id":"https:\/\/ror.org\/03wwr4r78","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s13258-024-01491-0","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T07:02:38Z","timestamp":1710399758000},"page":"541-555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The effect of canagliflozin on gut microbiota and metabolites in type 2 diabetic mice"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6153-6480","authenticated-orcid":false,"given":"Li","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jideng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guitao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongxiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoming","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"1491_CR1","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","volume":"70","author":"A Agus","year":"2021","unstructured":"Agus A, Clement K, Sokol H (2021) Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut 70:1174\u20131182. https:\/\/doi.org\/10.1136\/gutjnl-2020-323071","journal-title":"Gut"},{"key":"1491_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41574-019-0266-7","volume":"15","author":"TR Ahmad","year":"2019","unstructured":"Ahmad TR, Haeusler RA (2019) Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs. Nat Rev Endocrinol 15:701\u2013712. https:\/\/doi.org\/10.1038\/s41574-019-0266-7","journal-title":"Nat Rev Endocrinol"},{"key":"1491_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40168-018-0470-z","volume":"6","author":"NA Bokulich","year":"2018","unstructured":"Bokulich NA, Kaehler BD, Rideout JR, Dillon M, Bolyen E, Knight R, Huttley GA, Gregory Caporaso J (2018) Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2\u2019s q2-feature-classifier plugin. Microbiome 6:90. https:\/\/doi.org\/10.1186\/s40168-018-0470-z","journal-title":"Microbiome"},{"key":"1491_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP (2016) DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods 13:581\u2013583. https:\/\/doi.org\/10.1038\/nmeth.3869","journal-title":"Nat Methods"},{"key":"1491_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s42255-018-0017-4","volume":"1","author":"PD Cani","year":"2019","unstructured":"Cani PD, Van Hul M, Lefort C, Depommier C, Rastelli M, Everard A (2019) Microbial regulation of organismal energy homeostasis. Nat Metab 1:34\u201346. https:\/\/doi.org\/10.1038\/s42255-018-0017-4","journal-title":"Nat Metab"},{"key":"1491_CR6","doi-asserted-by":"publisher","first-page":"625913","DOI":"10.3389\/fcimb.2021.625913","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhou J, Wang L (2021) Role and mechanism of Gut Microbiota in Human Disease. Front Cell Infect Microbiol 11:625913. https:\/\/doi.org\/10.3389\/fcimb.2021.625913","journal-title":"Front Cell Infect Microbiol"},{"key":"1491_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cell.2013.12.016","volume":"156","author":"F De Vadder","year":"2014","unstructured":"De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, B\u00e4ckhed F, Mithieux G (2014) Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156:84\u201396. https:\/\/doi.org\/10.1016\/j.cell.2013.12.016","journal-title":"Cell"},{"key":"1491_CR8","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM de Vos","year":"2022","unstructured":"de Vos WM, Tilg H, Van Hul M, Cani PD (2022) Gut microbiome and health: mechanistic insights. Gut 71:1020\u20131032. https:\/\/doi.org\/10.1136\/gutjnl-2021-326789","journal-title":"Gut"},{"key":"1491_CR9","doi-asserted-by":"publisher","first-page":"159234","DOI":"10.1016\/j.bbalip.2022.159234","volume":"1867","author":"L Deng","year":"2022","unstructured":"Deng L, Yang Y, Xu G (2022) Empagliflozin ameliorates type 2 diabetes mellitus-related diabetic nephropathy via altering the gut microbiota. Biochim Biophys Acta Mol Cell Biol Lipids 1867:159234. https:\/\/doi.org\/10.1016\/j.bbalip.2022.159234","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"1491_CR10","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2217\/fmb-2017-0059","volume":"12","author":"M Esgalhado","year":"2017","unstructured":"Esgalhado M, Kemp JA, Damasceno NR, Fouque D, Mafra D (2017) Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease. Future Microbiol 12:1413\u20131425. https:\/\/doi.org\/10.2217\/fmb-2017-0059","journal-title":"Future Microbiol"},{"key":"1491_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan Y, Pedersen O (2021) Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 19:55\u201371. https:\/\/doi.org\/10.1038\/s41579-020-0433-9","journal-title":"Nat Rev Microbiol"},{"key":"1491_CR12","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.2337\/dc10-0612","volume":"33","author":"E Ferrannini","year":"2010","unstructured":"Ferrannini E, Ramos SJ, Salsali A, Tang W, List JF (2010) Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes Care 33:2217\u20132224. https:\/\/doi.org\/10.2337\/dc10-0612","journal-title":"Diabetes Care"},{"key":"1491_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/nu14173531","author":"S Hata","year":"2022","unstructured":"Hata S, Okamura T, Kobayashi A, Bamba R, Miyoshi T, Nakajima H, Kitagawa N, Hashimoto Y, Majima S, Senmaru T et al (2022) Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db\/db Mice. Nutrients. https:\/\/doi.org\/10.3390\/nu14173531","journal-title":"Nutrients"},{"key":"1491_CR14","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/dom.12149","volume":"15","author":"N Inagaki","year":"2013","unstructured":"Inagaki N, Kondo K, Yoshinari T, Maruyama N, Susuta Y, Kuki H (2013) Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study. Diabetes Obes Metab 15:1136\u20131145. https:\/\/doi.org\/10.1111\/dom.12149","journal-title":"Diabetes Obes Metab"},{"key":"1491_CR15","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F (2016) From Dietary Fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165:1332\u20131345. https:\/\/doi.org\/10.1016\/j.cell.2016.05.041","journal-title":"Cell"},{"key":"1491_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/dom.12188","volume":"16","author":"CS Kovacs","year":"2014","unstructured":"Kovacs CS, Seshiah V, Swallow R, Jones R, Rattunde H, Woerle HJ, Broedl UC (2014) Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial. Diabetes Obes Metab 16:147\u2013158. https:\/\/doi.org\/10.1111\/dom.12188","journal-title":"Diabetes Obes Metab"},{"key":"1491_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jcmgh.2021.01.011","volume":"12","author":"J Leonhardt","year":"2021","unstructured":"Leonhardt J, Haider RS, Sponholz C, Leonhardt S, Drube J, Spengler K, Mihaylov D, Neugebauer S, Kiehntopf M, Lambert NA et al (2021) Circulating bile acids in liver failure activate TGR5 and induce Monocyte Dysfunction. Cell Mol Gastroenterol Hepatol 12:25\u201340. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.01.011","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1491_CR18","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1681\/asn.2019101029","volume":"31","author":"YJ Li","year":"2020","unstructured":"Li YJ, Chen X, Kwan TK, Loh YW, Singer J, Liu Y, Ma J, Tan J, Macia L, Mackay CR et al (2020) Dietary Fiber protects against Diabetic Nephropathy through short-chain fatty acid-mediated activation of G protein-coupled receptors GPR43 and GPR109A. J Am Soc Nephrol 31:1267\u20131281. https:\/\/doi.org\/10.1681\/asn.2019101029","journal-title":"J Am Soc Nephrol"},{"key":"1491_CR19","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1194\/jlr.RA120001021","volume":"61","author":"S Marion","year":"2020","unstructured":"Marion S, Desharnais L, Studer N, Dong Y, Notter MD, Poudel S, Menin L, Janowczyk A, Hettich RL, Hapfelmeier S et al (2020) Biogeography of microbial bile acid transformations along the murine gut. J Lipid Res 61:1450\u20131463. https:\/\/doi.org\/10.1194\/jlr.RA120001021","journal-title":"J Lipid Res"},{"key":"1491_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112857","author":"MM Marron","year":"2022","unstructured":"Marron MM, Orwoll ES, Cawthon PM, Lane NE, Newman AB, Cauley JA (2022) Oxylipins Associated with D3-Creatine Muscle Mass\/Weight and Physical Performance among Community-Dwelling Older Men. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232112857","journal-title":"Int J Mol Sci"},{"key":"1491_CR21","doi-asserted-by":"publisher","first-page":"e000043","DOI":"10.1099\/mgen.0.000043","volume":"2","author":"POS Martin","year":"2016","unstructured":"Martin POS, Lawley JC, Browne TD, Harris HP, Bernalier-Donadille HMB, Duncan A, O\u2019Toole SH PW, K PS, H JF (2016) Polysaccharide utilization loci and nutritional specialization in a dominant group of butyrate-producing human colonic Firmicutes. Microb Genom 2:e000043. https:\/\/doi.org\/10.1099\/mgen.0.000043","journal-title":"Microb Genom"},{"key":"1491_CR22","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, B\u011blohl\u00e1vek J et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995\u20132008. https:\/\/doi.org\/10.1056\/NEJMoa1911303","journal-title":"N Engl J Med"},{"key":"1491_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41467-021-27766-8","volume":"13","author":"M Misheva","year":"2022","unstructured":"Misheva M, Kotzamanis K, Davies LC, Tyrrell VJ, Rodrigues PRS, Benavides GA, Hinz C, Murphy RC, Kennedy P, Taylor PR et al (2022) Oxylipin metabolism is controlled by mitochondrial beta-oxidation during bacterial inflammation. Nat Commun 13:139. https:\/\/doi.org\/10.1038\/s41467-021-27766-8","journal-title":"Nat Commun"},{"key":"1491_CR24","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/dc20-2257","volume":"44","author":"NT Mueller","year":"2021","unstructured":"Mueller NT, Differding MK, Zhang M, Maruthur NM, Juraschek SP, Miller ER 3rd, Appel LJ, Yeh HC (2021) Metformin affects gut microbiome composition and function and circulating short-chain fatty acids: a Randomized Trial. Diabetes Care 44:1462\u20131471. https:\/\/doi.org\/10.2337\/dc20-2257","journal-title":"Diabetes Care"},{"key":"1491_CR25","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/aps.2018.24","volume":"39","author":"MA Nayeem","year":"2018","unstructured":"Nayeem MA (2018) Role of oxylipins in cardiovascular diseases. Acta Pharmacol Sin 39:1142\u20131154. https:\/\/doi.org\/10.1038\/aps.2018.24","journal-title":"Acta Pharmacol Sin"},{"key":"1491_CR26","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1007\/s00125-018-4647-6","volume":"61","author":"M Olivares","year":"2018","unstructured":"Olivares M, Neyrinck AM, P\u00f6tgens SA, Beaumont M, Salazar N, Cani PD, Bindels LB, Delzenne NM (2018) The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice. Diabetologia 61:1838\u20131848. https:\/\/doi.org\/10.1007\/s00125-018-4647-6","journal-title":"Diabetologia"},{"key":"1491_CR27","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M et al (2020) Cardiovascular and renal outcomes with Empagliflozin in Heart failure. N Engl J Med 383:1413\u20131424. https:\/\/doi.org\/10.1056\/NEJMoa2022190","journal-title":"N Engl J Med"},{"key":"1491_CR28","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1038\/s41467-020-18928-1","volume":"11","author":"FC Pereira","year":"2020","unstructured":"Pereira FC, Wasmund K, Cobankovic I, Jehmlich N, Herbold CW, Lee KS, Sziranyi B, Vesely C, Decker T, Stocker R et al (2020) Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization. Nat Commun 11:5104. https:\/\/doi.org\/10.1038\/s41467-020-18928-1","journal-title":"Nat Commun"},{"key":"1491_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature18309","volume":"534","author":"RJ Perry","year":"2016","unstructured":"Perry RJ, Peng L, Barry NA, Cline GW, Zhang D, Cardone RL, Petersen KF, Kibbey RG, Goodman AL, Shulman GI (2016) Acetate mediates a microbiome-brain-\u03b2-cell axis to promote metabolic syndrome. Nature 534:213\u2013217. https:\/\/doi.org\/10.1038\/nature18309","journal-title":"Nature"},{"key":"1491_CR30","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Glockner FO (2013) The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41:D590\u2013596. https:\/\/doi.org\/10.1093\/nar\/gks1219","journal-title":"Nucleic Acids Res"},{"key":"1491_CR31","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/oby.22175","volume":"26","author":"M Rastelli","year":"2018","unstructured":"Rastelli M, Knauf C, Cani PD (2018) Gut microbes and health: a focus on the mechanisms linking microbes, obesity, and related disorders. Obes (Silver Spring) 26:792\u2013800. https:\/\/doi.org\/10.1002\/oby.22175","journal-title":"Obes (Silver Spring)"},{"key":"1491_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","volume":"7","author":"JM Ridlon","year":"2016","unstructured":"Ridlon JM, Harris SC, Bhowmik S, Kang DJ, Hylemon PB (2016) Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 7:22\u201339. https:\/\/doi.org\/10.1080\/19490976.2015.1127483","journal-title":"Gut Microbes"},{"key":"1491_CR33","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.jacc.2019.01.056","volume":"73","author":"CG Santos-Gallego","year":"2019","unstructured":"Santos-Gallego CG, Requena-Ibanez JA, San Antonio R, Ishikawa K, Watanabe S, Picatoste B, Flores E, Garcia-Ropero A, Sanz J, Hajjar RJ et al (2019) Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics. J Am Coll Cardiol 73:1931\u20131944. https:\/\/doi.org\/10.1016\/j.jacc.2019.01.056","journal-title":"J Am Coll Cardiol"},{"key":"1491_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2020.00025","volume":"11","author":"YP Silva","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in Gut-Brain communication. Front Endocrinol (Lausanne) 11:25. https:\/\/doi.org\/10.3389\/fendo.2020.00025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1491_CR35","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.cmet.2015.09.028","volume":"22","author":"V Singh","year":"2015","unstructured":"Singh V, Chassaing B, Zhang L, San Yeoh B, Xiao X, Kumar M, Baker MT, Cai J, Walker R, Borkowski K et al (2015) Microbiota-dependent hepatic lipogenesis mediated by Stearoyl CoA Desaturase 1 (SCD1) promotes metabolic syndrome in TLR5-Deficient mice. Cell Metab 22:983\u2013996. https:\/\/doi.org\/10.1016\/j.cmet.2015.09.028","journal-title":"Cell Metab"},{"key":"1491_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40168-019-0628-3","volume":"7","author":"Z Song","year":"2019","unstructured":"Song Z, Cai Y, Lao X, Wang X, Lin X, Cui Y, Kalavagunta PK, Liao J, Jin L, Shang J et al (2019) Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome. Microbiome 7:9. https:\/\/doi.org\/10.1186\/s40168-019-0628-3","journal-title":"Microbiome"},{"key":"1491_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.chom.2020.05.005","volume":"28","author":"MT Sorbara","year":"2020","unstructured":"Sorbara MT, Littmann ER, Fontana E, Moody TU, Kohout CE, Gjonbalaj M, Eaton V, Seok R, Leiner IM, Pamer EG (2020) Functional and genomic variation between human-derived isolates of Lachnospiraceae reveals Inter- and intra-species diversity. Cell Host Microbe 28:134\u2013146e134. https:\/\/doi.org\/10.1016\/j.chom.2020.05.005","journal-title":"Cell Host Microbe"},{"key":"1491_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8040573","author":"M Vacca","year":"2020","unstructured":"Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M (2020) The Controversial Role of Human Gut Lachnospiraceae. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms8040573","journal-title":"Microorganisms"},{"key":"1491_CR39","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000360010","volume":"39","author":"J Wong","year":"2014","unstructured":"Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND (2014) Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol 39:230\u2013237. https:\/\/doi.org\/10.1159\/000360010","journal-title":"Am J Nephrol"},{"key":"1491_CR40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s13238-020-00814-7","volume":"12","author":"J Wu","year":"2021","unstructured":"Wu J, Wang K, Wang X, Pang Y, Jiang C (2021) The role of the gut microbiome and its metabolites in metabolic diseases. Protein Cell 12:360\u2013373. https:\/\/doi.org\/10.1007\/s13238-020-00814-7","journal-title":"Protein Cell"},{"key":"1491_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jchromb.2018.02.040","volume":"1083","author":"M Zeng","year":"2018","unstructured":"Zeng M, Cao H (2018) Fast quantification of short chain fatty acids and ketone bodies by liquid chromatography-tandem mass spectrometry after facile derivatization coupled with liquid-liquid extraction. J Chromatogr B Analyt Technol Biomed Life Sci 1083:137\u2013145. https:\/\/doi.org\/10.1016\/j.jchromb.2018.02.040","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1491_CR42","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1463-1326.2010.01216.x","volume":"12","author":"L Zhang","year":"2010","unstructured":"Zhang L, Feng Y, List J, Kasichayanula S, Pfister M (2010) Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight. Diabetes Obes Metab 12:510\u2013516. https:\/\/doi.org\/10.1111\/j.1463-1326.2010.01216.x","journal-title":"Diabetes Obes Metab"},{"key":"1491_CR43","doi-asserted-by":"publisher","first-page":"e000717","DOI":"10.1136\/bmjdrc-2019-000717","volume":"7","author":"M Zhang","year":"2019","unstructured":"Zhang M, Feng R, Yang M, Qian C, Wang Z, Liu W, Ma J (2019) Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats. BMJ Open Diabetes Res Care 7:e000717. https:\/\/doi.org\/10.1136\/bmjdrc-2019-000717","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1491_CR44","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","volume":"33","author":"X Zheng","year":"2021","unstructured":"Zheng X, Chen T, Jiang R, Zhao A, Wu Q, Kuang J, Sun D, Ren Z, Li M, Zhao M et al (2021) Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab 33:791\u2013803e797. https:\/\/doi.org\/10.1016\/j.cmet.2020.11.017","journal-title":"Cell Metab"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-024-01491-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-024-01491-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-024-01491-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T08:09:38Z","timestamp":1713341378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13258-024-01491-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1491"],"URL":"https:\/\/doi.org\/10.1007\/s13258-024-01491-0","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"value":"1976-9571","type":"print"},{"value":"2092-9293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]},"assertion":[{"value":"22 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that\u00a0they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}